Luca Di Leo
Copenhagen, 2100, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Inhibition of ABCG2 by SCO-101 Enhances Chemotherapy Efficacy in Cancer.
Journal: International journal of molecular sciences
Published: February 19, 2025
AMBRA1 levels predict resistance to MAPK inhibitors in melanoma.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: June 13, 2024
Ambra1 modulates the tumor immune microenvironment and response to PD-1 blockade in melanoma.
Journal: Journal for immunotherapy of cancer
Published: February 21, 2023
Thiopurine 6TG treatment increases tumor immunogenicity and response to immune checkpoint blockade.
Journal: Oncoimmunology
Published: December 22, 2022
Metabolic modelling-based in silico drug target prediction identifies six novel repurposable drugs for melanoma.
Journal: Cell death & disease
Published: October 03, 2022
GSNOR deficiency promotes tumor growth via FAK1 S-nitrosylation.
Journal: Cell reports
Published: August 08, 2022
AMBRA1 and FAK1: crosstalking for improved targeted therapy in melanoma.
Journal: Molecular & cellular oncology
Published: October 07, 2021
AMBRA1 has an impact on melanoma development beyond autophagy.
Journal: Autophagy
Published: June 22, 2021
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Journal: Autophagy
Published: February 26, 2021
Loss of Ambra1 promotes melanoma growth and invasion.
Journal: Nature communications
Published: July 22, 2020
Last Updated: 09/26/2026